232 related articles for article (PubMed ID: 12544696)
1. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696
[TBL] [Abstract][Full Text] [Related]
2. On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.
de Boer NK; Derijks LJ; Gilissen LP; Hommes DW; Engels LG; de-Boer SY; den Hartog G; Hooymans PM; Mäkelburg AB; Westerveld BD; Naber AH; Mulder CJ; de Jong DJ
World J Gastroenterol; 2005 Sep; 11(35):5540-4. PubMed ID: 16222751
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
Belaiche J; Desager JP; Horsmans Y; Louis E
Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
[TBL] [Abstract][Full Text] [Related]
4. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
Bayoumy AB; van Liere ELSA; Simsek M; Warner B; Loganayagam A; Sanderson JD; Anderson S; Nolan J; de Boer NK; Mulder CJJ; Ansari A
BMC Gastroenterol; 2020 Sep; 20(1):296. PubMed ID: 32917155
[TBL] [Abstract][Full Text] [Related]
6. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
Goldenberg BA; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913
[TBL] [Abstract][Full Text] [Related]
7. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
Almer SH; Hjortswang H; Hindorf U
Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
[TBL] [Abstract][Full Text] [Related]
8. Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series.
Bayoumy AB; Jagt JZ; van Wering HM; de Ridder L; Hummel T; Wolters VM; Stapelbroek J; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ;
J Pediatr Gastroenterol Nutr; 2022 Dec; 75(6):e111-e115. PubMed ID: 36136124
[TBL] [Abstract][Full Text] [Related]
9. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry.
Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L
Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine.
Bastida G; Alvarez-Sotomayor D; Aguas M; Iborra M; Del Hoyo J; Béjar-Serrano S; Garrido-Marín A; Valero-Pérez E; Nos P
Gastroenterol Hepatol; 2024 May; 47(5):473-480. PubMed ID: 38072359
[TBL] [Abstract][Full Text] [Related]
11. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.
Cuffari C; Hunt S; Bayless T
Gut; 2001 May; 48(5):642-6. PubMed ID: 11302961
[TBL] [Abstract][Full Text] [Related]
12. A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.
Teml A; Schwab M; Harrer M; Miehsler W; Schaeffeler E; Dejaco C; Mantl M; Schneider B; Vogelsang H; Reinisch W
Scand J Gastroenterol; 2005 Oct; 40(10):1205-13. PubMed ID: 16265777
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease.
Derijks LJ; Gilissen LP; Engels LG; Bos LP; Bus PJ; Lohman JJ; van Deventer SJ; Hommes DW; Hooymans PM
Ther Drug Monit; 2006 Feb; 28(1):45-50. PubMed ID: 16418693
[TBL] [Abstract][Full Text] [Related]
14. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
Broekman MMTJ; Coenen MJH; van Marrewijk CJ; Wanten GJA; Wong DR; Verbeek ALM; Klungel OH; Hooymans PM; Guchelaar HJ; Scheffer H; Derijks LJJ; de Jong DJ;
Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
van Asseldonk DP; Seinen ML; de Boer NK; van Bodegraven AA; Mulder CJ
J Crohns Colitis; 2012 Feb; 6(1):95-101. PubMed ID: 22261533
[TBL] [Abstract][Full Text] [Related]
16. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
Bonaz B; Boitard J; Marteau P; Lémann M; Coffin B; Flourié B; Belaiche J; Cadiot G; Metman EH; Cortot A; Colombel JF;
Aliment Pharmacol Ther; 2003 Aug; 18(4):401-8. PubMed ID: 12940925
[TBL] [Abstract][Full Text] [Related]
17. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.
Gisbert JP; González-Lama Y; Maté J
Am J Gastroenterol; 2007 Jul; 102(7):1518-27. PubMed ID: 17391318
[TBL] [Abstract][Full Text] [Related]
19. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease.
Gupta P; Gokhale R; Kirschner BS
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):450-4. PubMed ID: 11698762
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.
Wright S; Sanders DS; Lobo AJ; Lennard L
Gut; 2004 Aug; 53(8):1123-8. PubMed ID: 15247179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
